Advertisement

Antepartum Management of Women with Cardiovascular Disease

  • Koichiro NiwaEmail author
Chapter

Abstract

Cardiac disease is a major cause of maternal death. The number of such cardiac patients at risk is expected to grow. Women with pulmonary hypertension, severe left ventricular outflow stenosis, cyanotic congenital heart disease, aortic root dilatation, cardiac dysfunction, and mechanical valves have a high risk. The most frequent complications during pregnancy and delivery are heart failure and arrhythmias. Risk stratification for pregnancy and heart disease relates to the functional status of the patient and is lesion specific. Timely prepregnancy counseling should be offered to all women with heart disease in order to prevent avoidable pregnancy-related risks. Adequate care during pregnancy, delivery, and the postpartum period requires a multidisciplinary team approach with cardiologists, obstetricians, and anesthesiologists and other related disciplines. Successful pregnancy is feasible for most women with heart disease with a relatively low risk when appropriate counseling and optimal care are provided.

Keywords

Cardiovascular disease Adult congenital heart disease Congenital heart disease Cardiac failure Arrhythmia 

References

  1. 1.
    Niwa K, Aomi S, Akagi T, et al Diagnosis and treatment of cardiovascular diseases (2009 Joint Working Groups Report). Guidelines for indication and management of pregnancy and delivery in women with heart disease (JCS 2010, revised). http://www.j-circ.or.jp/guideline/pdf/JCS2010niwa.h.pdf
  2. 2.
    JCS Joint Working Group (2012) Guidelines for indication and management of pregnancy and delivery in women with heart disease (JCS 2010) digest version. Circ J 76:240–260CrossRefGoogle Scholar
  3. 3.
    Gelson E, Ogueh O, Johnson M (2006) Cardiac changes in normal pregnancy. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 29–44Google Scholar
  4. 4.
    Mabie WC, DiSessa TG, Crocker LG et al (1994) A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 170:849–856CrossRefGoogle Scholar
  5. 5.
    Poppas A, Shroff SG, Korcarz CE et al (1997) Serial assessment of the cardiovascular system in normal pregnancy. Circulation 95:2407–2415CrossRefGoogle Scholar
  6. 6.
    Niwa K, Perloff JK, Bhuta SM et al (2001) Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103:393–400CrossRefGoogle Scholar
  7. 7.
    Katsuragi S, Ueda K, Yamanaka K et al (2011) Pregnancy-associated aortic dilatation or dissection in Japanese women with Marfan syndrome. Circ J 75:2545–2551CrossRefGoogle Scholar
  8. 8.
    Niwa K, Tateno S, Akagi T et al (2007) Arrhythmia and reduced heart rate variability during pregnancy in women with congenital heart disease and previous reparative surgery. Int J Cardiol 122:143–148CrossRefGoogle Scholar
  9. 9.
    Ohuchi H, Tanabe Y, Kamiya C et al (2013) Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease. Circ J 77:470–476CrossRefGoogle Scholar
  10. 10.
    Kamiya C, Nakatani S, Hashimoto S et al (2008) Role of echocardiography in assessing pregnant women with and without heart disease. J Echocardiogr 6:29–38CrossRefGoogle Scholar
  11. 11.
    Colman JM, Silversides CK, Sermer M et al (2006) Cardiac monitoring during pregnancy. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 67–77Google Scholar
  12. 12.
    DeWilde JP, Rivers AW, Price DL (2005) A review of the current use of magnetic resonance imaging in pregnancy and safety implications for fetus. Prog Biophys Mol Biol 87:335–353CrossRefGoogle Scholar
  13. 13.
    Silka M, Hardy B, Menashe V et al (1998) A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 32:245–251CrossRefGoogle Scholar
  14. 14.
    Gatzoulis MA, Balaji S, Webber SA et al (2000) Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicenter study. Lancet 356:975–981CrossRefGoogle Scholar
  15. 15.
    Shotan A, Ostrzega E, Mehra A et al (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Caridiol 79:1061–1064CrossRefGoogle Scholar
  16. 16.
    Joglar JA, Page RL (2001) Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 16:40–45CrossRefGoogle Scholar
  17. 17.
    Brodsky M, Doria R, Allen B et al (1992) New-onset ventricular tachycardia during pregnancy. Am Heart J 123:933–941CrossRefGoogle Scholar
  18. 18.
    Tateno S, Niwa K, Nakazawa M et al (2003) Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy – multicenter study. Circ J 67:992–997CrossRefGoogle Scholar
  19. 19.
    Dalvi BV, Chaudhuri A, Kulkarni HL et al (1992) Therapeutic guidelines for congenital heart block presenting in pregnancy. Obstet Gynecol 79:802–804PubMedPubMedCentralGoogle Scholar
  20. 20.
    Egidy AG, Cassater D, Landzberg M et al (2013) The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. Int J Cardiol 168:1847–1852CrossRefGoogle Scholar
  21. 21.
    Kamiya CA, Iwamiya T, Neki R et al (2012) Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of Fallot. Circ J 76:957–963CrossRefGoogle Scholar
  22. 22.
    Siu SC, Sermer M, Harrison DA et al (1997) Risk and predictors for pregnancy-related complications in woman with heart disease. Circulation 96:2789–2794CrossRefGoogle Scholar
  23. 23.
    Buttar HS (1997) An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 176:61–71CrossRefGoogle Scholar
  24. 24.
    Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451CrossRefGoogle Scholar
  25. 25.
    Presbitero P, Prever SB, Brusca A (1996) Interventional cardiology in pregnancy. Eur Heart J 17:182–188CrossRefGoogle Scholar
  26. 26.
    Wloch A, Respondek-Liberska M, Sysa A et al (2004) Significant aortic and pulmonary valve stenosis in the prenatal period: diagnosis, treatment and outcome: a two-centre study. Acta Cardiol 59:242–243PubMedGoogle Scholar
  27. 27.
    Parry AJ, Westaby S (1996) Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 61:1865–1869CrossRefGoogle Scholar
  28. 28.
    Colman JM, Sermer M, Seaward PG et al (2000) Congenital heart disease in pregnancy. Cardiol Rev 8:166–173CrossRefGoogle Scholar
  29. 29.
    Child J, Perloff JK, Koos B (2009) Management of pregnancy and contraception in congenital heart disease. In: Perloff JK, Child JS, Aboulhosn J (eds) Congenital heart disease in adults, 3rd edn. Saunders/Elsevier, Philadelphia, pp 194–220CrossRefGoogle Scholar
  30. 30.
    Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (2007 Joint Working Groups Report) Guidelines for the Prevention and Treatment of Infective Endocarditis (JCS 2008). http://www.j-circ.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf
  31. 31.
    Stuart G (2006) Maternal endocarditis. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 267–282Google Scholar
  32. 32.
    Child JS, Pegues DA, Perloff JK (2009) Infective endocarditis and congenital heart disease. In: Perloff JK, Child JS, Aboulhosn J (eds) Congenital heart disease in adults, 3rd edn. Saunders/Elsevier, Philadelphia, pp 168–193CrossRefGoogle Scholar
  33. 33.
    Siu SC, Sermer M, Colman JM et al (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104:515–521CrossRefGoogle Scholar
  34. 34.
    Khairy P, Ouyang DW, Fernandes SM et al (2006) Pregnancy outcomes in women with congenital heart disease. Circulation 113:517–524CrossRefGoogle Scholar
  35. 35.
    Siu SC, Colman JM, Sorensen S et al (2002) Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105:2179–2184CrossRefGoogle Scholar
  36. 36.
    Briggs GG, Freeman RK, Yaffe SJ (eds) (2008) Drugs in pregnancy and lactation, 8th edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2019

Authors and Affiliations

  1. 1.Cardiovascular CenterSt Luke’s International HospitalChuo-kuJapan

Personalised recommendations